Drug pricing policy is shifting fast, and pharmacy leaders are caught in the middle; balancing patient access with mounting payer cost pressures. This panel brings together pharmacy executives to unpack how Medicare drug price negotiation, 340B scrutiny, and evolving payer strategies are reshaping pharmacy's approach to affordability and reimbursement. Attendees will leave with practical, peer-tested strategies for navigating policy disruption while keeping patients at the center of care.